Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 46 of 46 entries
View as:

Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS)

Phase: N/A Priority: Normal
NCT ID: NCT03783377 Org: User:
Start: 03/08/19 End: 02/11/21 Due: 02/11/22

Study of ARO-APOC3 in Adults With Mixed Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT04998201 Org: User:
Start: 09/28/21 End: 08/14/23 Due: 08/14/24

Study of AROSOD-1 in Adult Participants With Amyotrophic Lateral Sclerosis (ALS)

Phase: N/A Priority: Normal
NCT ID: NCT05949294 Org: User:
Start: 01/31/24 End: 03/31/25 Due: 03/31/26

Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia

Phase: N/A Priority: Normal
NCT ID: NCT06347133 Org: User:
Start: 05/21/24 End: 10/31/26 Due: 10/31/27

Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)

Phase: N/A Priority: Normal
NCT ID: NCT02577029 Org: User:
Start: 12/31/15 End: 12/31/16 Due: 12/31/17

Safety and Tolerability Study of ARC-520 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01872065 Org: User:
Start: 07/31/13 End: 11/30/14 Due: 11/30/15

Study of ARO-RAGE in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05533294 Org: User:
Start: 11/29/22 End: 02/08/24 Due: 02/08/25

Study of Plozasiran in Adults With Severe Hypertriglyceridemia

Phase: N/A Priority: Normal
NCT ID: NCT06347016 Org: User:
Start: 07/23/24 End: 10/31/26 Due: 10/31/27

Study of ARO-CFB in Adult Healthy Volunteers and Patients With Complement-Mediated Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT06209177 Org: User:
Start: 04/22/24 End: 03/31/27 Due: 03/31/28

Study of ARO-DM1 in Subjects With Type 1 Myotonic Dystrophy

Phase: N/A Priority: Normal
NCT ID: NCT06138743 Org: User:
Start: 03/04/24 End: 06/30/25 Due: 06/30/26

Safety, Tolerability and Pharmacodynamic Effect of Fazirsiran (TAK-999, ARO-AAT)

Phase: N/A Priority: Normal
NCT ID: NCT03945292 Org: User:
Start: 08/07/19 End: 09/18/23 Due: 09/18/24

Safety, Tolerability and Effect of ARC-AAT Injection on Circulating and Intrahepatic Alpha-1 Antitrypsin Levels

Phase: N/A Priority: Normal
NCT ID: NCT02900183 Org: User:
Start: 10/31/16 End: 11/30/16 Due: 11/30/17

Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia

Phase: N/A Priority: Normal
NCT ID: NCT06347003 Org: User:
Start: 07/22/24 End: 10/31/26 Due: 10/31/27

Study of ARO-APOC3 (Plozasiran) in Adults With Familial Chylomicronemia Syndrome (FCS)

Phase: N/A Priority: Normal
NCT ID: NCT05089084 Org: User:
Start: 01/11/22 End: 04/30/26 Due: 04/30/27

Study of ARO-C3 in Adult Healthy Volunteers and Patients With Complement Mediated Renal Disease

Phase: N/A Priority: Normal
NCT ID: NCT05083364 Org: User:
Start: 02/02/22 End: 06/30/25 Due: 06/30/26

Study of ARO-MMP7 Inhalation Solution in Healthy Subjects and Patients With Idiopathic Pulmonary Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT05537025 Org: User:
Start: 01/30/23 End: 09/30/25 Due: 09/30/26

Study of ARO-DUX4 in Adult Patients With Facioscapulohumeral Muscular Dystrophy Type 1

Phase: N/A Priority: Normal
NCT ID: NCT06131983 Org: User:
Start: 02/26/24 End: 09/30/25 Due: 09/30/26

Study of ARO-MUC5AC in Healthy Subjects and Patients With Muco-Obstructive Lung Disease

Phase: N/A Priority: Normal
NCT ID: NCT05292950 Org: User:
Start: 06/27/22 End: 11/12/24 Due: 11/12/25

Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2

Phase: N/A Priority: Normal
NCT ID: NCT06672445 Org: User:
Start: 12/17/24 End: 09/30/26 Due: 09/30/27

Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia

Phase: N/A Priority: Normal
NCT ID: NCT06822790 Org: User:
Start: 03/31/25 End: 07/31/28 Due: 07/31/29

Study of ARO-ANG3 in Adults With Mixed Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT04832971 Org: User:
Start: 06/28/21 End: 09/25/24 Due: 09/25/25